EGFR is an extensively studied biomarker in head and neck squamous cell carcinoma
(HNSCC). In this review, we discuss the prognostic and predictive role of EGFR in HNSCC …

Biomarkers are broadly classified as genomic, proteomic, or metabolomic. Molecular biology
and oncology research studies on oral cancer biomarkers focus on identifying key biological …

Mutations in tumor suppressor p53 protein can occur at different phases of malignant
transformation and affect the patient's prognosis. This study aimed to evaluate the …

Oral cancer has become one of the most aggressive types of cancer, killing 140,000 people
worldwide every year. Current treatments for oral cancer include surgery and radiation …

The prognostic role of epidermal growth factor receptor (EGFR) in head and neck squamous
cell carcinoma (HNSCC) remains controversial. The goal of this study was to summarize …

Objective Immunohistochemical over expression of p53 is considered as a marker of poor
prognosis in many cancers. Therefore, we aimed to evaluate immunohistochemical …

Objectives: Our aim was to analyze the clinical, pathological, and outcome characteristics of
oral squamous cell carcinomas (OSCC) from a population of the north of Portugal. Material …

The unnotified or undifferentiable early stages of oral squamous cell carcinoma (OSCC)
progression are the prime reasons for late-stage detection and poor survival outcomes of …

The aim of this systematic review and meta-analysis was to evaluate the current evidence in
relation to the clinicopathological and prognostic significance of epidermal growth factor …

Objectives/Hypothesis Epidermal growth factor receptor (EGFR) is a type I transmembrane
glycoprotein that is overexpressed in a wide variety of malignancies, including oral …